Richard Straube

Richard Straube

No open positions remaining

Net worth: 13 $ as of 2026-06-29

74 year
Health Technology
Consumer Services
Finance

Profile

Richard C.
Straube
worked as Senior Director-Clinical Research & Immunology at Centocor, Inc. from 1988 to 1993.
From 1993 to 1995, served as Director-Medical Affairs at T Cell Sciences, Inc. Between 1995 and 1997, held the position of Director-Clinical Investigations at Ohmeda, Inc. From 1998 to 2007, was Chief Scientific Officer and Executive VP-R&D at INO Therapeutics LLC.
Held the role of Chief Medical Officer at Critical Biologics Corp.
from 2007 to 2009.
From 2009 to 2014, was Chief Medical Officer at Stealth BioTherapeutics, Inc. Served as Chief Medical Officer & Senior Vice President at Soligenix, Inc. from 2014 to 2025.
Also held positions as Faculty Member at the University of California San Diego and Principal at Inomax LLC (Florida).
Education includes a doctorate from The University of Chicago in 1977 and a graduate degree from the London School of Hygiene & Tropical Medicine in 1982.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-10 34 ( 0% ) 13 $ 2026-06-29

Former positions of Richard Straube

CompaniesPositionEnd
SOLIGENIX, INC. Chief Tech/Sci/R&D Officer 2025-08-11
Chief Tech/Sci/R&D Officer 2013-12-31
Chief Tech/Sci/R&D Officer 2008-12-31
Chief Tech/Sci/R&D Officer 2006-12-31
Ohmeda, Inc.
Corporate Officer/Principal 1997-01-01
See the detail of Richard Straube's experience

Training of Richard Straube

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

91

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Finance

Ohmeda, Inc.

Health Technology

  1. Stock Market
  2. Insiders
  3. Richard Straube